Laverock Therapeutics
PrivateLast Round
Grant
Jun 1, 2026
Total Funding Raised
$30.86M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Laverock Therapeutics operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Grant round in June 2026.
Laverock Therapeutics is a biotechnology company that develops a gene silencing platform designed to engineer programmable and adaptive cell therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Laverock Therapeutics Comparables
Compare Laverock Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Concinnity Genetics | 82% | |
| Epigenic Therapeutics | 79% | |
| CellOrigin Biotech | 79% |
For institutional investors. Book with your work email.
Laverock Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 1, 2026 | ||||
| Seed | Jun 30, 2025 | ||||
| Grant | Oct 30, 2023 | ||||
| Seed | Sep 28, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Laverock Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Future Planet Capital Regional | Seed, Grant |
| Mercia Ventures | Seed |
| Tekfen Ventures | Seed |
| Innovate UK | Grant |
| UK Innovation & Science Seed Fund | Grant |
| Calculus Capital | Seed |
| Eos Advisory | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 1199% MoM to 1.8K.
- Jun 1, 2026
Secured $3M in grant funding.
For institutional investors. Book with your work email.
Laverock Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Laverock Therapeutics's valuation, stock price, and market status.
Is Laverock Therapeutics a public or private company?
Laverock Therapeutics is a private company.
What is the current stock price of Laverock Therapeutics?
Laverock Therapeutics is a private company, so its shares have no public market price. Caplight tracks Laverock Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Laverock Therapeutics worth (valuation)?
Valuation information for Laverock Therapeutics is not publicly available.
Can I buy Laverock Therapeutics stock?
Laverock Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Laverock Therapeutics's last funding round?
Laverock Therapeutics's most recent funding round was Grant on June 1, 2026.
Who are the main investors in Laverock Therapeutics?
Key investors in Laverock Therapeutics include Innovate UK, Calculus Capital.
Will Laverock Therapeutics IPO soon?
No public IPO plans have been announced for Laverock Therapeutics.
How can I track Laverock Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Laverock Therapeutics's shares on secondary markets.